BEVERLY, Mass., July 14, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Firm”), a molecular diagnostics firm that develops a totally automated fast pathogen detection system, right this moment introduced its strategic relationship with Wolf Greenfield, an mental property (IP) legislation agency, specializing in patents, licensing and royalty transactions, post-grant proceedings, and trademark and copyrights.
Dr. Jack Regan, LexaGene’s CEO and Founder, said, “As LexaGene continues to develop, it’s essential to not solely defend however nurture and develop the mental property belongings of the Firm. I’m more than happy to have the nationally acknowledged experience of Wolf Greenfield on board for all of our strategic IP and licensing wants shifting ahead.”
“The addition of Wolf Greenfield to our crew will likely be essential as we proceed increase our patent portfolio,” continued Dr. Regan. “And mixing the strengths of Wolf Greenfield for IP legislation and licensing, together with Latham & Watkins for securities legislation, provides us the capabilities of two of probably the most revered legislation corporations within the U.S. of their respective fields, as we proceed to execute on our progress aims.”
Including Wolf Greenfield to its illustration portfolio strengthens LexaGene’s positioning in direction of presumably listing its common shares on the Nasdaq Capital Market.
The Firm additionally introduced that Dr. Regan will likely be talking on the “Entry to Giving” investor convention on Thursday, July 15. Entry to Giving is a first-of-its-kind, digital investor convention, the place corporations from microcap as much as mega-cap can have the chance to current their firm’s imaginative and prescient and take part in conferences with certified buyers, all to profit a variety of charities. To register or to be taught extra go to, https://www.accesstogiving.com/. To hearken to LexaGene’s presentation register right here: https://www.webcaster4.com/Webcast/Page/2744/41999. The audio recording will likely be posted to the LexaGene web site, at a later date.
On Behalf of the Board of Administrators
Dr. Jack Regan
Chief Govt Officer & Chairman
About Wolf Greenfield
For almost a century, Wolf Greenfield has helped its shoppers defend their most useful mental property. With over 150 authorized professionals primarily based in Boston and New York, the agency gives a full vary of IP companies, together with patent prosecution and litigation; post-grant proceedings, together with IPRs; opinions and strategic counseling; licensing; mental property audits and due diligence; trademark and copyright prosecution and litigation; and different points associated to the commercialization of mental property.
About LexaGene Holdings Inc.
LexaGene is a molecular diagnostics firm that develops molecular diagnostic techniques for pathogen detection and genetic testing for different molecular markers for on-site fast testing in veterinary diagnostics, meals security and to be used in open-access markets comparable to medical analysis, agricultural testing, and biodefense. Finish-users merely want to gather a pattern, load it onto the instrument with a pattern preparation cartridge, enter pattern ID and press ‘go.’ The MiQLab™ system delivers glorious sensitivity, specificity, and breadth of detection and may return ends in roughly two hours. The distinctive open-access function is designed for customized testing in order that end-users can load their very own real-time PCR assays onto the instrument to focus on any genetic goal of curiosity.
The TSX Enterprise Change Inc. has by no means handed upon the deserves of the proposed transaction and has neither accepted nor disapproved the contents of this press launch. Neither TSX Enterprise Change nor its Regulation Companies Supplier (as that time period is outlined within the insurance policies of the TSX Enterprise Change) accepts duty for the adequacy or accuracy of this launch.
This information launch accommodates forward-looking data, which entails recognized and unknown dangers, uncertainties and different components that will trigger precise occasions to vary materially from present expectation. Necessary components — together with the provision of funds, the outcomes of financing efforts, the success of expertise growth efforts, the associated fee to obtain vital elements, efficiency of the instrument, market acceptance of the expertise, regulatory acceptance, and licensing points — that would trigger precise outcomes to vary materially from the Firm’s expectations as disclosed within the Firm’s paperwork filed on occasion on SEDAR (see www.sedar.com). Readers are cautioned to not place undue reliance on these forward-looking statements, which converse solely as of the date of this press launch. The corporate disclaims any intention or obligation, besides to the extent required by legislation, to replace or revise any forward-looking statements, whether or not on account of new data, future occasions or in any other case.
Company Contact: Gail Winslow Director of Company Advertising firstname.lastname@example.org 978.482.6237 email@example.com 800.215.1824